Skip to main content
SpringerLink
Log in

Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy

  • Guidelines
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fisher ND, Hollenberg NK. Renin inhibition: what are the therapeutic opportunities? J Am Soc Nephrol. 2005;16:592–9.

    Article  CAS  PubMed  Google Scholar 

  2. Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK, AVOID Study Investigators. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med. 2008;358:2433–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, All India Institute of Medical Sciences, New Delhi, 110029, India

    Ankur Gupta, Ambar Khaira, Bakshish Singh, Dipankar M. Bhowmik & Suresh C. Tiwari

  2. BD-10, Vishakha enclave, Pitampura, New Delhi, 110088, India

    Ankur Gupta

Authors
  1. Ankur Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ambar Khaira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bakshish Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dipankar M. Bhowmik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suresh C. Tiwari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ankur Gupta.

Additional information

Ankur Gupta, act as guarantor for the other authors.

About this article

Cite this article

Gupta, A., Khaira, A., Singh, B. et al. Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy. Clin Exp Nephrol 13, 402–403 (2009). https://doi.org/10.1007/s10157-009-0130-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-009-0130-5

Keywords

Search

Navigation